株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

3D医用画像・外科用画像プラットフォームの世界市場

Global 3D Medical and Surgical Imaging Platform Market

発行 BCC Research 商品コード 773867
出版日 ページ情報 英文 229 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
3D医用画像・外科用画像プラットフォームの世界市場 Global 3D Medical and Surgical Imaging Platform Market
出版日: 2019年01月10日 ページ情報: 英文 229 Pages
概要

世界における3D医用画像・外科用画像プラットフォーム市場規模は、2018年の45億米ドルから2023年には約104億米ドルへ達すると予測され、同期間中は18.1%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界における3D医用画像・外科用画像プラットフォーム市場について調査分析し、市場の概要、世界市場の動向分析とCAGR予測、市場における可能性の特徴化・定量化、主な市場成長の促進要因・技術進歩・地域ダイナミクス・現在の市場動向の分析、ベンダー情勢、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場・技術背景

  • イントロダクション
  • 調査範囲
  • 規制
  • 投資分析
  • 3D医用画像・外科用画像プラットフォーム:コンポーネント別
  • 3D医用画像・外科用画像プラットフォーム:用途別
  • 3D医用画像・外科用画像プラットフォーム:展開別
  • 3D医用画像・外科用画像プラットフォーム:エンドユーザー別
  • 産業の成長促進要因
  • 効率的な医療インフラの一部としてのハイブリッド手術室の導入
  • 医療部門における自動化技術の利用拡大
  • 慢性疾患の診断・モニタリングにおける3D画像の需要増加
  • 新たな革新的ソリューション:市場におけるプラットフォームプロバイダー

第4章 市場分析:コンポーネント別

  • ハードウェア
  • ソフトウェア
  • サービス

第5章 市場分析:用途別

  • 超音波
  • デジタルX線 (DR)
  • MRI
  • CT
  • 核医学
  • マンモグラフィー
  • 内視鏡
  • その他 (腹腔鏡、X線、ほか)

第6章 市場分析:展開タイプ別

  • オンプレミス型プラットフォーム
  • クラウド型プラットフォーム
  • ウェブ型プラットフォーム

第7章 市場分析:エンドユーザー別

  • 病院
  • 通院
  • 診断センター
  • 研究センター

第8章 市場背景:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第9章 産業構造

  • 産業におけるイノベーション
  • サプライチェーン分析
  • サプライチェーンにおける機会

第10章 企業プロファイル

  • AMBRA HEALTH
  • ARTERYS
  • BRAINLAB AG
  • キャノンメディカルシステムズ (東芝を獲得)
  • DEPUY SYNTHES
  • ESAOTE SPA
  • FOVIA
  • GE HEALTHCARE
  • KITWARE INC.
  • KONINKLIJKE PHILIPS NV
  • LEXMARK INTERNATIONAL INC.
  • MACH7 TECHNOLOGIES LTD.
  • MCKESSON CORP.
  • MEDTRONIC INC.
  • NAVEGATIUM
  • NDS SURGICAL IMAGING LLC
  • NERVEVISION INC.
  • オリンパス
  • PIE MEDICAL IMAGING BV
  • PLANMECA OY
  • QUIBIM SL
  • SIEMENS HEALTHCARE
  • STRYKER CORP.
  • SURGICAL THEATER LLC
  • WHITECLOUDS
図表

List of Tables

  • Summary Table: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 1: Report Scope
    • Table 2: Examples of Medical Software Under the European Union
    • Table 3: Medical Software Regulations
    • Table 4: Investments in 3D Medical and Surgical Imaging
    • Table 5: Common Robot-Assisted, Minimally Invasive Surgeries
    • Table 6: Common (Non-robot) Assisted Minimally Invasive Surgeries
    • Table 7: Benefits of 3D Imaging Techniques for Patient and Physicians
    • Table 8: Global Geriatric Population (60 Years+), by Region, 2015-2050
    • Table 9: 10 Leading Causes of Burden of Disease Worldwide, 2004 vs. 2030
    • Table 10: Key Investments in Medical Imaging Systems and Technologies Since 2015
    • Table 11: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 12: Comparison of the Configurations of Preamplifiers Used in Imagers
    • Table 13: Global Market for 3D Medical and Surgical Imaging Platform Hardware, by Region, Through 2023
    • Table 14: Global Deaths from Cancer, 2015 and 2030
    • Table 15: Global Deaths from CVD, 2015 and 2030
    • Table 16: Global CVD Deaths, 2015
    • Table 17: Global Market for 3D Medical and Surgical Imaging Platform Software, by Region, Through 2023
    • Table 18: 3D Medical and Surgical Imaging Services
    • Table 19: Global Market for 3D Medical and Surgical Imaging Platform Services, by Region, Through 2023
    • Table 20: Global Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 21: Some Major Uses of Ultrasound
    • Table 22: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Ultrasound Systems, by Region, Through 2023
    • Table 23: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Digital Radiography, by Region, Through 2023
    • Table 24: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
    • Table 25: Oral Cavity and Pharynx Cancer as a Percentage of All New Cancer Cases in the U.S., 2018
    • Table 26: New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
    • Table 27: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in MRI Systems, by Region, Through 2023
    • Table 28: Global Number of Deaths Caused by Selected Chronic Diseases, 2015
    • Table 29: Rising Chronic Diseases in the United States, 2000-2030
    • Table 30: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Computed Tomography Systems, by Region, Through 2023
    • Table 31: Top 10 Causes of Death, 2016
    • Table 32: Percentage of Global Population with Cancer, 2005-2016
    • Table 33: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging Systems, by Region, Through 2023
    • Table 34: Number of DALYs for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 and 2030
    • Table 35: Deaths Attributable to Neurological Disorders, 2005, 2015 and 2030
    • Table 36: YLDs Associated with Neurological Disorders and Other Diseases and Injuries with Neurological Sequelae Projected for 2005, 2015 and 2030
    • Table 37: Global Market for the Application of 3D Medical and Surgical Imaging Platforms Mammography Systems, by Region, Through 2023
    • Table 38: Recent Strategic Initiatives of Key Market Players
    • Table 39: Age-Specific Probabilities of Developing Invasive Female Breast Cancer, 2013-2023
    • Table 40: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
    • Table 41: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
    • Table 42: Comparison of Endoscopic Systems
    • Table 43: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Endoscopy, by Region, Through 2023
    • Table 44: Global Disease Burden Rates, by Cancer Type, 2016
    • Table 45: Global Market for 3D Medical and Surgical Imaging Platforms in Other Applications, by Region, Through 2023
    • Table 46: Advantages of Laparoscopic Surgery over Conventional Open Surgery
    • Table 47: Benefits and Drawbacks of On-premise, Cloud-based and Web-based Platforms
    • Table 48: Global Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 49: Global Market for On-premise 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
    • Table 50: Companies That Offer Novel On-premise 3D Medical and Surgical Imaging Platforms with Features
    • Table 51: Benefits and Drawbacks of On-premise 3D Medical and Surgical Imaging Platforms
    • Table 52: Benefits and Drawbacks of Cloud-Based 3D Medical and Surgical Imaging Platforms
    • Table 53: Companies That Offer Cloud-based 3D Medical and Surgical Imaging Platforms with Features
    • Table 54: Global Market for Cloud-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
    • Table 55: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
    • Table 56: Benefits and Drawbacks of Web-based 3D Medical and Surgical Imaging Platforms
    • Table 57: Companies That Offer Web-based 3D Medical and Surgical Imaging Platforms with Features
    • Table 58: Global Market for Web-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
    • Table 59: Global Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 60: Global Market for 3D Medical and Surgical Imaging Platforms in Hospitals, by Region, Through 2023
    • Table 61: Most Common Cancers Causing Death Globally, by Type, 2015
    • Table 62: Estimated Female Breast Cancer Deaths in the U.S., by Age, 2017
    • Table 63: U.S. Hospitals, by Type, 2016
    • Table 64: Global Prevalence of Dementia, 2015-2050
    • Table 65: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
    • Table 66: Global Market for 3D Medical and Surgical Imaging Platforms in Ambulatory Healthcare Settings, by Region, Through 2023
    • Table 67: Global Market for 3D Medical and Surgical Imaging Platforms in Diagnostic Centers, by Region, Through 2023
    • Table 68: Technological Advancements, 2015-2018
    • Table 69: Advanced Product Development, 2015 and 2018
    • Table 70: Global Healthcare Expenditure, 2012 and 2015
    • Table 71: Distribution of Healthcare Expenditures, by Country, 2017
    • Table 72: Alzheimer's Dementia in the United States, by Age Group, 2017
    • Table 73: Global Causes of Mortality, by Gender, 2015 (or Nearest Year)
    • Table 74: Global Market for 3D Medical and Surgical Imaging Platform in Research Centers, by Region, Through 2023
    • Table 75: Estimated U.S. Medical and Health Research Expenditures, Federal Government Agencies, 2014 and 2015
    • Table 76: R&D Expenditures, by Selected Scientific Agencies, 2015
    • Table 77: German Government R&D Spending, by Research Area, 2016 and 2017
    • Table 78: North American Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
    • Table 79: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 80: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Deployment, Through 2023
    • Table 81: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 82: U.S. Estimated New Cancer Cases (Males), by Type, 2017
    • Table 83: U.S. Estimated New Cancer Cases (Females), by Type, 2017
    • Table 84: 10 Most Common Chronic Conditions for Adults 65+
    • Table 85: Chronic Disease, 2005-2030
    • Table 86: U.S. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 87: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 88: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 89: New Cancer Cases and Estimated Deaths in Canada, 2016
    • Table 90: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 91: Canadian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 92: Total Healthcare Expenditure in Europe, by Category, 2018
    • Table 93: European Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
    • Table 94: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 95: Deaths from CVD and Number of People Living with CVD in the United Kingdom, 2015-2017
    • Table 96: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 97: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 98: U.K. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 99: French Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 100: Musculoskeletal Disorders in France, by Variable Type, 2016
    • Table 101: French Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 102: French Health Spending and Financing, 2005-2015
    • Table 103: French Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 104: French Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 105: Frequency of Cardiac Procedures in Germany, 2016
    • Table 106: German Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 107: Geriatric Population in Germany, 2015-2030
    • Table 108: German Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 109: German Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 110: German Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 111: Hospitals in Germany, by Category, 2015 and 2016
    • Table 112: Estimates of Cancer Incidence in Spain, by Type of Cancer, 2015
    • Table 113: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 114: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 115: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 116: Spanish Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 117: ROE Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 118: ROE Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 119: ROE Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 120: ROE Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 121: Breast Cancer in Norway, 2014 and 2015
    • Table 122: Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
    • Table 123: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 124: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 125: Chinese Cancer Prevalence, by Gender and Type, 2016
    • Table 126: Current Chinese Cancer Grants, by Gender and Cancer Type, 2017
    • Table 127: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 128: Healthcare Facilities in China, as of October 2016
    • Table 129: Chinese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 130: Indian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 131: Diagnostics Imaging Investments in India, 2016
    • Table 132: Indian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 133: Indian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 134: Number of Aesthetic Surgical Procedures Performed in India, 2016
    • Table 135: Indian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 136: Japanese Aging Population and Future Estimates, 2010-2040
    • Table 137: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 138: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 139: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 140: Japanese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 141: Australian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 142: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
    • Table 143: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
    • Table 144: 10 Most Common Causes of Death from Cancer in Australia (Male), 2017
    • Table 145: 10 Most Common Causes of Death from Cancer in Australia (Females), 2017
    • Table 146: Australian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 147: Australian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 148: Australian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 149: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 150: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 151: Medical Tourism Revenue, Malaysia, 2011-2016
    • Table 152: Foreign Patients, Malaysia, 2011-2016
    • Table 153: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 154: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 155: Rest of the World Market for 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
    • Table 156: ROW 60+ Population, by Region
    • Table 157: New Cases of Cancer, by Gender in Brazil, 2016
    • Table 158: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 159: 60+ Population in Brazil, 2015-2050
    • Table 160: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 161: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 162: Projected Healthcare Spending in Argentina, 2014 and 2040
    • Table 163: Leading Causes of Death in Argentina and Percentage Change between 2005 and 2016
    • Table 164: Latin American Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 165: MEA Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
    • Table 166: Department of Health, Abu Dhabi Cancer Screening Recommendations
    • Table 167: MEA 3D Market for Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
    • Table 168: MEA Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
    • Table 169: MEA Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
    • Table 170: Innovations within the Industry
    • Table 171: 3D Medical and Surgical Imaging Instruments and Their Components
    • Table 172: Mandatory Regulatory Guidelines for Suppliers and Manufacturers
    • Table 173: Suppliers and Manufacturers for 3D Medical and Surgical Imaging Devices in the U.S.
    • Table 174: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in China
    • Table 175: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in the Rest of Asia-Pacific
    • Table 176: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in Europe
    • Table 177: Ambra Health: Product Portfolio
    • Table 178: Ambra Health: Recent Developments, 2018
    • Table 179: Arterys: Product Portfolio
    • Table 180: Arterys: Recent Developments, 2018
    • Table 181: Brainlab AG: Product Portfolio
    • Table 182: Canon Medical Systems Ltd.: Product Portfolio
    • Table 183: Canon Medical Systems Ltd.: Recent Development, 2018
    • Table 184: DePuy Synthes: Product Portfolio
    • Table 185: Esaote SpA: Product Portfolio
    • Table 186: Esaote SpA: Recent Development, 2017
    • Table 187: Fovia: Product Portfolio
    • Table 188: Fovia: Recent Developments, 2015-2017
    • Table 189: GE Healthcare: Product Portfolio
    • Table 190: GE Healthcare: Recent Developments, 2015-2017
    • Table 191: Kitware Inc.: Product Portfolio
    • Table 192: Koninklijke Philips NV: Product Portfolio
    • Table 193: Koninklijke Philips NV: Recent Development 2017 and 2018
    • Table 194: Lexmark International Inc.: Product Portfolio
    • Table 195: Mach7 Technologies Ltd.: Product Portfolio
    • Table 196: Mach7 Technologies Ltd.: Recent Developments, 2016 and 2017
    • Table 197: McKesson Corp.: Product Portfolio
    • Table 198: Medtronic Inc.: Product Portfolio
    • Table 199: Medtronic Inc.: Recent Developments 2015-2018
    • Table 200: Navegatium: Product Portfolio
    • Table 201: NDS Surgical Imaging LLC: Product Portfolio
    • Table 202: NerveVision Inc.: Product Portfolio
    • Table 203: Olympus Corp.: Product Portfolio
    • Table 204: Olympus Corp.: Recent Developments, 2017
    • Table 205: PIE Medical Imaging BV: Product Portfolio
    • Table 206: PIE Medical Imaging BV: Recent Developments, 2017 and 2018
    • Table 207: Planmeca OY: Product Portfolio
    • Table 208: Quibim SL: Product Portfolio
    • Table 209: Siemens Healthcare: Product Portfolio
    • Table 210: Siemens Healthcare: Recent Developments, 2017
    • Table 211: Stryker Corp.: Product Portfolio
    • Table 212: Stryker Corp.: Recent Developments, 2015
    • Table 213: Surgical Theater LLC: Product Portfolio
    • Table 214: Surgical Theater LLC: Recent Development, 2015
    • Table 215: WhiteClouds: Product Portfolio
    • Table 216: WhiteClouds: Recent Developments, 2016

List of Figures

  • Summary Figure: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, 2017-2023
    • Figure 1: Annual Market Revenues for Robot-Assisted, Minimally Invasive Surgery, 2015-2025
    • Figure 2: Annual Market Revenues from Sales of Endoscopy Devices, 2015-2024
    • Figure 3: Cost Breakdown: Owning Hybrid Operating Rooms, by Equipment Type
    • Figure 4: Cloud Computing in Medical and Surgical Imaging
    • Figure 5: Trends in Rising Aged Population Around the World, 2014-2022
    • Figure 6: Trends in Number of Deaths Due to Chronic Diseases, 2005-2020
    • Figure 7: Rising Trends in Healthcare Spending, by Payment Source, 2015-2040
    • Figure 8: Block Diagram of LDS Imaging System
    • Figure 9: Structure of Software
    • Figure 10: Global Deaths from Cancer, 2015 and 2030
    • Figure 11: Global Deaths from CVD, 2015 and 2030
    • Figure 12: Global CVD Deaths, by Type, 2015
    • Figure 13: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
    • Figure 14: Oral Cavity and Pharynx Cancer versus All New Cancer Cases in the U.S., 2018
    • Figure 15: Percentage of New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
    • Figure 16: Global Number of Deaths Caused by Selected Chronic Disease, 2015
    • Figure 17: Rising Chronic Diseases in the United States, 2000-2030
    • Figure 18: Top 10 Causes of Death, 2016
    • Figure 19: Percentage of Global Population with Cancer, 2005-2016
    • Figure 20: Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging
    • Figure 21: Factors Affecting Breast Cancer Risk in Women
    • Figure 22: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
    • Figure 23: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
    • Figure 24: Global Disease Burden Rates, by Cancer Type, 2016
    • Figure 25: Applications of Laparoscopy
    • Figure 26: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
    • Figure 27: Steps to Derive Final 3D Image through Web-based Surgical Imaging Platform
    • Figure 28: Major Market Drivers
    • Figure 29: Advantages of 3D Mammography versus 2D
    • Figure 30: Most Common Cancers Causing Death Globally, by Type, 2015
    • Figure 31: U.S. Hospitals, by Type, 2016
    • Figure 32: Global Prevalence of Dementia, 2015-2050
    • Figure 33: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
    • Figure 34: Major Factors Driving the Growth of Global Diagnostic Centers Market
    • Figure 35: Applications of 3D Medical and Surgical Imaging Platforms in Diagnostic Centers
    • Figure 36: Global Healthcare Expenditure, 2012 and 2015
    • Figure 37: Distribution of Healthcare Expenditures, by Country, 2017
    • Figure 38: Alzheimer's Dementia in the United States, by Age Group, 2017
    • Figure 39: Chronic Diseases, 2005-2030
    • Figure 40: Total Healthcare Expenditure in Europe, by Category, 2018
    • Figure 41: Musculoskeletal Disorders in France, by Variable Type, 2016
    • Figure 42: French Health Spending and Financing, 2005-2015
    • Figure 43: Geriatric Population in Germany, 2000-2030
    • Figure 44: Hospitals in Germany, by Category, 2015 and 2016
    • Figure 45: Role of Medical Radiation Imaging in Cancer Management
    • Figure 46: Breast Cancer in Norway, 2014 and 2015
    • Figure 47: Chinese Cancer Prevalence, by Gender and Type, 2016
    • Figure 48: Japanese Aging Population and Future Estimates, 2010-2040
    • Figure 49: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
    • Figure 50: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
    • Figure 51: Projected Healthcare Spending in Argentina, 2014 and 2040
    • Figure 52: Industry Structure for 3D Medical and Surgical Imaging Market
    • Figure 53: Factors Influencing Supplier Contracts Within 3D Medical and Surgical Imaging Market
    • Figure 54: Medical Technology R&D Process
    • Figure 55: R&D from Conceptualization to Development
    • Figure 56: Marketing Matrix for Medical Technology Products
    • Figure 57: Medical and Surgical Imaging Instruments Manufacturing Process
    • Figure 58: Global Healthcare Expenditure, by Institutional Spending, 2015-2025
    • Figure 59: Block-Chain Capabilities Across Supply Chain
    • Figure 60: Global Logistics Robotics Market Revenue Forecast, 2015-2021
目次
Product Code: HLC216A

Report Highlights:

The global market for 3D medical and surgical imaging platforms should increase from $4.5 billion in 2018 to nearly $10.4 billion in 2023 at a compound annual growth rate (CAGR) of 18.1% for 2018-2023.

Software market should increase from $2.2 billion in 2018 to $5.2 billion by 2023 at a CAGR of 18.5% through 2023.

Services market should increase from $816 million in 2018 to $1.9 billion by 2023 at a CAGR of 17.9% through 2023.

Report Scope:

The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by components into hardware, software and services. Revenue forecasts for 2018-2023 are given for each segment and regional market with estimated value derived from the revenue of manufacturers' total revenues. The main geographic markets-North America, Europe, Asia Pacific and Rest of World (ROW) are included.

The report also includes a discussion of the major players across each region in the 3D medical and surgical imaging platforms market. Further, it explains the major drivers and regional dynamics of the global 3D medical and surgical imaging platforms market and current trends within the industry.

Key industry acquisitions and strategic alliances are given for the three-year period 2015-2018 (June).

This report also examines the main patent trends within the industry and profiles 25 market players that deal in 3D medical and surgical imaging platforms.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global 3D medical and surgical imaging platforms market.

Report Includes:

  • 151 data tables and 66 additional tables
  • An overview of the global 3D medical and surgical imaging platform market
  • Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Characterization and quantification of the market potential for 3D medical and surgical imaging platform by geographical regions, components, applications, end users and mode of deployment
  • Discussion of major drivers, technological advancements and regional dynamics of the global 3D medical and surgical imaging platform market, and current trends within the industry
  • Assessment of the vendor landscape and detailed profiles of the major vendors in the global 3D medical and surgical imaging platform market
  • Company profiles of major players in the market, including Ambra Health, Esaote Spa, GE Healthcare, Koninklijke Philips NV, Medtronic Inc., Siemens Healthcare, Stryker Corp. and Whiteclouds

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Introduction
  • Report Scope
  • Regulations
    • United States
    • European Union
    • Australia
    • China
    • Japan
    • ASEAN
    • South Africa
  • Investment Analysis
  • 3D Medical and Surgical Imaging Platforms by Component
    • Hardware
    • Software
    • Services
  • 3D Medical and Surgical Imaging Platforms by Application
    • Ultrasound
    • Digital Radiography
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Nuclear Imaging
    • Mammography
  • 3D Medical and Surgical Imaging Platforms by Deployment
    • On-premise-based Platform
    • Cloud-based Platform
    • Web-based Platform
  • 3D Medical and Surgical Imaging Platform by End User
    • Hospitals
    • Ambulatory and Healthcare Settings
    • Diagnostic Centers
    • Research Centers
  • Industry Growth Drivers
    • Development of Modern Visualization Methods and Technology Platforms
    • High Adoption of Minimally Invasive Procedures
  • Adoption of Hybrid Operating Rooms as Part of an Efficient Medical Infrastructure
  • Increasing Use of Automation Technologies in the Healthcare Sector
  • Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
  • New Innovative Solutions by Platform Providers in the Market
    • Increasing Aging Population
    • Increased Prevalence of Chronic Diseases
    • Rising Healthcare Expenditures

Chapter 4: Market Breakdown by Component

  • Hardware
  • Software
  • Services

Chapter 5: Market Breakdown by Application

  • Ultrasound
    • 3D Ultrasound Scanning Techniques
    • Increasing Incidence of Infectious and Chronic Diseases Drives the Ultrasound Market
    • Research and Development in CVD
  • Digital Radiography
    • Advantages of X-Ray Machines
  • Magnetic Resonance Imaging
    • Advancements in 3D Imaging
  • Computed Tomography
    • 3D Surgical and Medical Imaging Platforms for CT Scan
    • Common Applications of CT Scans
    • Application of CT in Pediatric Patients
    • Benefits
    • Advancements in Imaging Systems
  • Nuclear Imaging
    • Market Drivers
    • Positron Emission Computed Tomography (PET) Imaging
    • Single Photon Emission Computed Tomography (SPECT) Imaging
    • Scintigraphy Imaging
    • Estimation of Disability-Adjusted Life Years (DALYs) for Neurological Diseases
    • Technological Advancements in Nuclear Imaging:
  • Mammography
  • Endoscopy
    • Advantages of 3D Endoscopy System
    • Types
    • Innovation and New Products
  • Others (Laparoscopy, X-ray, etc.)
    • Advancements in Laparoscopy

Chapter 6: Market Breakdown by Type of Deployment

  • On-premise-based Platforms
  • Cloud-based Platform
    • Benefits
    • Drawbacks
  • Web-based Platform
    • Benefits
    • Drawbacks

Chapter 7: Market Breakdown by End User

  • Hospitals
    • According to Breast Cancer (Australia)
    • Cancer Research U.K. Statistics
    • Increased Number of Hospitals Worldwide
    • Increasing Prevalence of Cardiovascular Diseases
    • Hybrid Operating Room
    • Patient-Centric Trend
  • Ambulatory and Healthcare Settings
  • Diagnostic Centers
    • Technological Advancements in 3D Medical and Surgical Imaging Platforms
    • Increasing Healthcare Expenditure
  • Research Centers

Chapter 8: Market Background by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Italy
    • Rest of Europe (ROE)
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Rest of the World (ROW)
    • Latin America
    • Middle East and Africa (MEA)

Chapter 9: Industry Structure

  • Innovations within the Industry
  • Supply Chain Analysis
    • Suppliers
    • Research and Development (R&D)
    • Manufacturing
    • Distribution
    • End Users
  • Opportunities in Supply Chain
    • Artificial Intelligence and Analytics
    • Block-Chain and Internet of Things (IoT)
    • Robotics

Chapter 10: Company Profiles

  • AMBRA HEALTH
  • ARTERYS
  • BRAINLAB AG
  • CANON MEDICAL SYSTEMS LTD. (ACQUIRED TOSHIBA CORP.)
  • DEPUY SYNTHES
  • ESAOTE SPA
  • FOVIA
  • GE HEALTHCARE
  • KITWARE INC.
  • KONINKLIJKE PHILIPS NV
  • LEXMARK INTERNATIONAL INC.
  • MACH7 TECHNOLOGIES LTD.
  • MCKESSON CORP.
  • MEDTRONIC INC.
  • NAVEGATIUM
  • NDS SURGICAL IMAGING LLC
  • NERVEVISION INC.
  • OLYMPUS CORP.
  • PIE MEDICAL IMAGING BV
  • PLANMECA OY
  • QUIBIM SL
  • SIEMENS HEALTHCARE
  • STRYKER CORP.
  • SURGICAL THEATER LLC
  • WHITECLOUDS
Back to Top